The pattern of metastases in breast cancer and the relation to estrogen receptor status
Kamby, C.; Rose, C.; Iversen, H.; Holm, N.V.; Andersen, K.W.; Thorpe, S.M.
Ugeskrift for Laeger 148(40): 2546-2548
1986
ISSN/ISBN: 0041-5782 PMID: 3775953 Document Number: 272299
Document emailed within 1 workday
Related Documents
Caldarola, L.; Calderini, P.; Volterrani, P.; Di Carlo, F.; Gaglia, P. 1983: The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer Italian Journal of Surgical Sciences 13(3): 179-185Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Kiang, D.T.; Frenning, D.H.; Gay, J.; Goldman, A.I.; Kennedy, B.J. 1980: Estrogen receptor status and response to chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2814-2817
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Kuo, S.H.; Lin, C.C.; Yu, S.C.; Liaw, K.Y.; Wei, T.C.; Chen, K.M. 1985: Relationship of DNA ploidy, cell kinetics, estrogen receptor and clinical status in patients with breast cancer Journal of the Formosan Medical Association 84(11): 1260-1269
Honig, A.; Gehrmann, M.; Kranke, P.; Keller, D.; Engel, J.B.; Hengstler, S.; Schmidt, M. 2014: Microtubule-associated protein tau correlates with estrogen receptor status but not with in vitro paclitaxel sensitivity in primary breast cancer European Journal of Gynaecological Oncology 35(5): 503-507
Tisman, G. 2009: Inhibition of HER2/estrogen receptor cross-talk, probable relation to prolonged remission of stage IV breast cancer: a case report Tumori 95(6): 804-807
DeWys, W.D.; Allegra, J.C.; Simon, R.; Lippman, M.B. 1980: A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites Cancer Research 40(7): 2423-2427
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Thorpe, S.M. 1987: Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method Cancer Research 47(24 Pt 1): 6572-6575
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Pervez, S. 1994: Why to measure estrogen receptor status in breast carcinomas? JPMA. Journal of the Pakistan Medical Association 44(6): 132-133
Surmacz, E.; Bartucci, M. 2004: Role of estrogen receptor alpha in modulating IGF-i receptor signaling and function in breast cancer Journal of Experimental and Clinical Cancer Research: Cr 23(3): 385-394
Avci, N.; Deligonul, A.; Tolunay, S.; Cubukcu, E.; Fatih Olmez, O.; Ulas, A.; Hartavi, M.; Kurt, E.; Evrensel, T. 2015: Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 45-49
Shao, Z.M.; Sheikh, M.S.; Ordonez, J.V.; Feng, P.; Kute, T.; Chen, J.C.; Aisner, S.; Schnaper, L.; LeRoith, D.; Roberts, C.T. 1992: IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma Cancer Research 52(18): 5100-5103
Masiuk, M. 2006: Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry Annales Academiae Medicae Stetinensis 52(2): 23-32
Ellinidi, V.N.; Anikeeva, N.V.; Goncharova, O.A.; Krasnozhon, D.A. 2005: Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status Voprosy Onkologii 51(2): 197-199